Wellgistics Health (WGRX) priced its IPO at $4.50 – the low end of its $4.50-to-$5.50 range – and sold all 900,000 shares – the number in the prospectus – to raise $4.05 million on Thursday night, Feb. 20, 2025. Shares of Wellgistics Health slipped in their NASDAQ debut, opening at $4.35 – down 15 cents from their IPO price – at 10:46 a.m. EST today – Friday, Feb. 21 – on volume of 87,423 shares, according to NASDAQ.
Craft Capital and D. Boral Capital (formerly EF Hutton) were the joint book-runners.
Wellgistics Health, based in Tampa, Florida, is a health-care holding company whose businesses include a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.
“We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors,” Wellgistics Health said in the prospectus.
Wellgistics Health is not profitable, according to financial statements in the prospectus. The company had a net loss of $3.6 million on revenue of $5.72 million for the 12 months that ended Sept. 30, 2024.
(For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on the IPOScoop.com website.)
Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board.
To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message.
Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions.
Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums) is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading. The SCOOP Rating does not reflect the opinions of anyone associated with IPOScoop.com. The SCOOP ratings should not be taken as investment advice. The rating merely reflects the opinion of the professionals at the time of publication and is subject to last-minute changes due to market conditions, changes in a specific offering and other factors, such as changes in the proposed offering terms and the shifting of investor interest in the IPO. The information offered is taken from sources we believe to be reliable, but we cannot guarantee the accuracy.